
Raoul Concepcion, MD, director, Comprehensive Prostate Center, discussed the best treatment option for a patient with metasatic castration-resistant prostate cancer (mCRPC) during the LUGPA Annual Meeting.

Your AI-Trained Oncology Knowledge Connection!


Published: November 28th 2016 | Updated: